CTK Biotech

10/12/2026

With clear results that aid patient and population-level surveillance, OnSite® H. pylori Ab Combo Rapid Test offers the precision and speed that clinicians need to quickly evaluate suspected H. pylori infection and begin patient management.

https://zurl.co/KIob1

10/05/2026

Inactive H. pylori infections can go undetected for years, only to become active later and cause chronic GI issues or even gastric cancer.

The OnSite® H. pylori Ab Combo Rapid Test is trusted worldwide to detect recent and past H. pylori infections, helping clinicians monitor patients at risk of active H. pylori infection and intervene before infections can progress.

Learn more at: https://zurl.co/FB9L9

09/28/2026

Preventable infections shouldn’t stand in the way of a healthy pregnancy. CTK’s OnSite® TORCH Panel Rapid Test helps identify treatable infections that threaten maternal and neonatal health, supporting earlier intervention and better outcomes for both mother and baby.
Learn More: https://zurl.co/POU4y

09/28/2026

Preventable infections shouldn’t stand in the way of a healthy pregnancy. CTK’s OnSite® TORCH Panel Rapid Test helps identify treatable infections that threaten maternal and neonatal health supporting earlier intervention and better outcomes for both mother and baby.

Learn More: https://zurl.co/NkcwB

09/21/2026

The OnSite® HIV/Syphilis Ab Combo Rapid Test detects antibodies for HIV and Syphilis in 15 minutes, offering clinicians a dual-target STD screening tool that improves workflow efficiency and supports timely care for both infections during a single patient visit.

Learn more at: https://zurl.co/rUkdG

09/11/2026

Millions around the world lack access to HIV testing services, which are essential for reducing HIV/AIDS-associated morbidities and mortalities. CTK’s OnSite® HIV ½ Ab Rapid Test provides an affordable, accessible solution for HIV testing in resource-limited settings.

Learn more: https://zurl.co/KvvqF

09/02/2026

September marks Prostate Cancer Awareness Month. Prostate cancer is the most common non-skin cancer diagnosed in men, with 1 in 8 men being diagnosed with prostate cancer in their lifetime. When detected early, the odds of survival are high!

CTK offers a PSA Semi-Quantitative Rapid Test to aid in the diagnosis of prostate cancer.
Learn more at https://zurl.co/GJAki

08/24/2026

Active H. pylori infections often cause GI symptoms treated by patients using antacids and PPIs, which can interfere with certain screening methodologies. In 10 minutes, the OnSite® H. pylori Ag Rapid Test provides clinicians with accurate results unaffected by common medications, reducing patient burden without compromising reliability.
Learn more at: https://zurl.co/yRtCL

08/20/2026

Approximately half the world population is at risk of contracting Dengue Fever—and the risk is even higher for people living in or visiting warmer, tropical regions where Aedes mosquitoes tend to thrive. This World Mosquito Day, learn how to protect yourself and your communities from Dengue outbreaks by visiting: https://zurl.co/2hinv

WHO fact sheet on dengue, providing information on symptoms, diagnostics and treatment, global burden, transmission, risk factors, prevention and control and WHO's work in this area.

07/20/2026

Backed by 20 years of use in clinical and emergency settings, CTK’s range of OnSite® Dengue Rapid Tests use state-of-the-art recombinant analytes to detect and differentiate Dengue IgG/IgM antibodies and NS1 antigens across all four serotypes, providing clinicians with point-of-care diagnostic aids with reproducible quality and a high standard for accuracy.

Learn more at: https://zurl.co/W2D6v